Company Tuoxin Pharmaceutical Group Co.,Ltd.

Company Tuoxin Pharmaceutical Group Co.,Ltd.

301089

CNE100004YC3

Pharmaceuticals

Equities

301089

CNE100004YC3

Pharmaceuticals

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sales per Business

Sales per region

Sector Generic Pharmaceuticals

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sales per Business

Sales per region

Sector Generic Pharmaceuticals

End-of-day quote Shenzhen S.E. Other stock markets 06:00:00 2024-05-15 pm EDT			5-day change	1st Jan Change
38.82 ^CNY	-2.46%		-9.11%	-28.12%

Apr. 22	Tuoxin Pharmaceutical Group Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Apr. 22	Tuoxin Pharmaceutical Group Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Tuoxin Pharmaceutical Group Co Ltd, formerly Xinxiang Tuoxin Pharmaceutical Co Ltd, is a Chinese company mainly engaged in the research and development, production and sales of nucleoside (acid) APIs and pharmaceutical intermediates. The Company's main products include pyrimidine series, purine series, nucleotide series, nucleoside series and other series of nucleoside (acid) products, including citicoline sodium, ribavirin, inosine, acyclovir, azvudine, cytosine, 5-fluorocytosine, cytidine, uridine and other raw materials and pharmaceutical intermediates. Its products are mainly used in the fields of virus, anti-tumor and nervous system drugs. The Company mainly distributes its products in domestic market and overseas markets.

Number of employees: 1,550

CNY in Million	2022	Weight	2023	Weight	Delta
Nucleoside 55.5 %	378	48.2 %	464	55.5 %	+22.71%
Nucleotide 17.5 %	206	26.3 %	146	17.5 %	-29.05%
Purine 17.5 %	125	15.9 %	146	17.5 %	+17.16%
Pyrimidine 5.7 %	49	6.2 %	48	5.7 %	-1.57%
Other 3.8 %	27	3.5 %	31	3.8 %	+15.36%

CNY in Million	2022	Weight	2023	Weight	Delta
China 90.0 %	699	89.1 %	752	90.0 %	+7.56%
Overseas 10.0 %	86	10.9 %	84	10.0 %	-2.38%

Managers	Title	Age	Since
Hui Juan Jiao DFI	Director of Finance/CFO	58	11-11-30
Tao Li CTO	Chief Tech/Sci/R&D Officer	43	05-06-30
Xiu Qiang Wang BRD	Director/Board Member	54	05-07-31
Yu Ying Cai BRD	Director/Board Member	61	05-07-31

Members of the board	Title	Age	Since
Xi Ning Yang CHM	Chairman	62	05-07-31
Lin Xian Sheng BRD	Director/Board Member	69	05-07-31
Yu Ying Cai BRD	Director/Board Member	61	05-07-31
Gui Rong Qu BRD	Director/Board Member	75	12-02-29
Xiu Qiang Wang BRD	Director/Board Member	54	05-07-31
Yan Shun Jin BRD	Director/Board Member	42	19-11-29
Liu Hao CHM	Chairman	57	11-11-30
Chun Hong Dong BRD	Director/Board Member	52	05-07-31
Yong Zeng Zhang BRD	Director/Board Member	54	11-11-30
Jian Wei Liu BRD	Director/Board Member	43	19-11-29

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	126,544,500	51,247,876 ( 40.50 %)	0	40.50 %

Name	Equities	%	Valuation
Lin Xian Sheng 23.57 %	18,164,661	23.57 %	84 M ¥
Hao Liu 7.613 %	5,867,825	7.613 %	27 M ¥
CSC Financial Xinxiang Tuoxin Associated Asset Management Plan 3.206 %	2,471,480	3.206 %	11 M ¥
Macro-Link Holdings Ltd. 1.904 %	1,467,700	1.904 %	7 M ¥
Yu Ying Cai 1.722 %	1,327,000	1.722 %	6 M ¥
Gui Rong Qu 1.250 %	963,625	1.250 %	4 M ¥
Xiu Qiang Wang 0.5260 %	405,467	0.5260 %	2 M ¥
Chun Hong Dong 0.4630 %	356,875	0.4630 %	2 M ¥
China Merchants Fund Management Co., Ltd. 0.2844 %	219,224	0.2844 %	1 M ¥
Invesco Great Wall Fund Management Co. Ltd. (Invt Mgmt) 0.2413 %	186,000	0.2413 %	860 456 ¥

Name	Equities	%	Valuation
Yu Ying Cai 8.137 %	3,980,775	8.137 %	18 M ¥
Gui Rong Qu 8.125 %	3,974,500	8.125 %	18 M ¥
Chun Hong Dong 4.142 %	2,026,000	4.142 %	9 M ¥
Xiu Qiang Wang 2.549 %	1,246,933	2.549 %	6 M ¥

Tuoxin Pharmaceutical Group Co., Ltd.

515 Kelong Avenue Hongqi District

453000, Xinxiang

http://www.tuoxinchem.com

address Tuoxin Pharmaceutical Group Co.,Ltd.(301089)

	1st Jan change	Capi.
TUOXIN PHARMACEUTICAL GROUP CO.,LTD.	-28.12%	680M
SUN PHARMACEUTICAL INDUSTRIES LTD.	+21.59%	44.15B
OTSUKA HOLDINGS CO., LTD.	+23.03%	23.02B
SANDOZ GROUP AG	+18.26%	15.33B
CIPLA LIMITED	+12.26%	13.74B
ZYDUS LIFESCIENCES LIMITED	+52.55%	12.16B
ONO PHARMACEUTICAL CO., LTD.	-10.02%	6.84B
THE MEDICINES COMPANY	-0.05%	6.79B
STADA ARZNEIMITTEL	-8.87%	5.73B
ASPEN PHARMACARE HOLDINGS LIMITED	+13.88%	5.66B

Generic Pharmaceuticals

Healthcare

Pharmaceuticals & Medical Research

Pharmaceuticals

Pharmaceuticals

Generic Pharmaceuticals